FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/101612 [Registered on: 20/01/2026] Trial Registered Prospectively
Last Modified On: 19/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Case Series 
Study Design  Other 
Public Title of Study   Evolving Homoeopathic management strategies for Irritable Bowel Syndrome. 
Scientific Title of Study   Evolving homoeopathic management strategies in patients with Irritable Bowel Syndrome: Retrospective case series study. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Pranita Chavan 
Designation  Post Graduate Student 
Affiliation  Dr. M.L.Dhawale Memorial Homoeopathic Institute, Palghar 
Address  308, Department of Practice of Medicine, 2nd floor, Dr. M.L.Dhawale Memorial Homoeopathic Institute, Palghar, Palghar- Boisar road, Opp. S.T. Workshop, Palghar, Dist. Palghar, Maharashtra,India

Palghar
MAHARASHTRA
401404
India 
Phone  8422962080  
Fax    
Email  pranita443@gmail.com   
 
Details of Contact Person
Scientific Query
 
Name  Dr Harshla Sarvagod 
Designation  Associate Professor 
Affiliation  Dr. M.L.Dhawale Memorial Homoeopathic Institute, Palghar 
Address  308, Department of practice of medicine, 2nd floor, Dr. M.L.Dhawale Memorial Homoeopathic Institute, Palghar, Palghar- Boisar road, Opp. S.T. Workshop, Palghar, Dist. Palghar, Maharashtra, India

Palghar
MAHARASHTRA
401404
India 
Phone  8108777599  
Fax    
Email  harshsarvagodr@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Harshla Sarvagod 
Designation  Associate Professor 
Affiliation  Dr. M.L.Dhawale Memorial Homoeopathic Institute, Palghar 
Address  308, Department of practice of medicine, 2nd floor, Dr. M.L.Dhawale Memorial Homoeopathic Institute, Palghar, Palghar- Boisar road, Opp. S.T. Workshop, Palghar, Dist. Palghar, Maharashtra, India

Palghar
MAHARASHTRA
401404
India 
Phone  8108777599  
Fax    
Email  harshsarvagodr@gmail.com  
 
Source of Monetary or Material Support  
Dr. M.L. Dhawale Memorial Trust Hospital, Palghar, Palghar-Boisar Road, Opp. S.T. Workshop, Dist. Palghar, Maharashtra, 401404. 
 
Primary Sponsor  
Name  Dr M L Dhawale Memorial Trust  
Address  Dr. M. L. Dhawale Memorial Homoeopathic Institute, Palghar, Palghar- Boisar road, Opp. S.T. Workshop, Palghar, Dist. Palghar - 401404, Maharashtra, India  
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Pranita Chavan  Dr. M.L.Dhawale Memorial Homoepathgic Institute  Room No. 308, Department of Practice Of Medicine, 2nd Floor, Dr. M.L. Dhawale Memorial Homoeopathic Institute, Opp. S.T. Workshop, Palghar, Dist. Palghar, Maharashtra, India.
Palghar
MAHARASHTRA 
8422962080

pranita443@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Dr. M.L.Dhawale Memorial Homoepathgic Institute, Palghar  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K58||Irritable bowel syndrome,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
Comparator Agent  nil  nil 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1. All diagnosed cases of Irritable bowel syndrome using the ROME IV criteria.
2. Above 18 years of age
3. Patient of all genders
4. Those case records that have been prescribed either of these- constitutional, acute, intercurrent or any other specific remedy.
5. Case record of patients having remedy registration judged by MONARCH criteria starting from 6 months up to 1 year with homoeopathic treatment.
6. Case records in which follow-ups have been taken meticulously based on the criteria formed.
 
 
ExclusionCriteria 
Details  1. Case records showing patient taking any other AYUS mode of treatment other than homoeopathy during the course of the treatment.
2. Patient with pre diagnosed GAD (Generalized Anxiety Disorder).
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To evolve the various management strategies considering different remedial approaches (constitutional, acute, intercurrent, specific remedies) and posology with the help of MONARCH criteria for managing cases of Irritable bowel syndrome by studying minimum 1 year follow.  1 year 6 months  
 
Secondary Outcome  
Outcome  TimePoints 
To study the commonly used homoeopathic remedies in treatment of irritable bowel syndrome after studying the follow ups for minimum 1 year of duration   1 year 6 months  
 
Target Sample Size   Total Sample Size="31"
Sample Size from India="31" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   02/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Irritable Bowel Syndrome is a functional gastrointestinal disorder where conventional treatments such as anti-diarrheals, stool bulking agents, and dietary modifications provide only symptomatic relief without addressing underlying causes. Research on homeopathy in IBS has shown mixed results, with some studies reporting global improvement but lacking detail on specific symptom changes, potency selection, posology, or strategies for managing acute exacerbations. To fill this gap, a systematic retrospective analysis of homeopathically treated IBS cases is proposed, focusing on disease trends, aggravating and predisposing factors, epidemiology, and individualized remedy strategies—including acute, chronic, intercurrent, and specific remedies—while evaluating potency selection and repetition in relation to patient susceptibility and sensitivity. This approach aims to establish clearer correlations between individualized homeopathic remedies and clinical outcomes, ultimately contributing to structured, evidence-based management strategies for IBS.


 
Close